Zandra Körner (Former)

1 – 4 of 4

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/med-zkr?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2018
Mark Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study
Fontes Oliveira, Cibely ^LU ; M. Soares Oliveira, Bernardo ^LU ; Körner, Zandra ^LU ; Harandi, Vahid ^LU and Durbeej-Hjalt, Madeleine ^LU (2018) In Scientific Reports
- Contribution to journal › Article
2016
Mark Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.
Körner, Zandra ^LU and Durbeej-Hjalt, Madeleine ^LU (2016) In PLoS ONE 11(1).
- Contribution to journal › Article
Mark Congenital muscular dystrophy with laminin α2 chain-deficiency. Initiation of disease and development of treatment
Körner, Zandra ^LU (2016)
- Thesis › Doctoral thesis (compilation)
2014
Mark Bortezomib Partially Improves Laminin α2 Chain-Deficient Muscular Dystrophy.
Körner, Zandra ^LU ; Fontes Oliveira, Cibely ^LU ; Holmberg, Johan K ^LU ; Carmignac, Virginie ^LU and Durbeej-Hjalt, Madeleine ^LU (2014) In American Journal of Pathology 184(5). p.1518-1528
- Contribution to journal › Article